Navigation Links
Mylan in Medical News

President Clinton and Mylan Chairman and CEO Robert J. Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug-Resistant HIV in Developing Countries

PITTSBURGH, Aug. 6 /PRNewswire-FirstCall/ -- President Bill Clinton, Mylan Chairman and CEO Robert J. Coury and Matrix Laboratories Founder and Vice Chairman N. Prasad today announced an important agreement to enable better, more affordable treatments for patients on "second-line" antire...

Andrew G. Cuneo Joins Mylan as Vice President of Global Business Development

PITTSBURGH, April 13 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced the appointment of former Merrill Lynch investment banker Andrew G. Cuneo as vice president of Global Business Development. Cuneo is responsible for coordinating Mylan's global business development and s...

Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations

PITTSBURGH, July 21 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL ) announced today the appointment of Daniel E. Crookshank as vice president - Investor Relations and as a member of the company's senior leadership team. Reporting to Chief Financial Officer Edward J. Borkowski, Crookshank is...

Mylan Chairman and CEO Robert J. Coury to Ring NASDAQ Stock Market Closing Bell

... PITTSBURGH, July 29 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that its Cha... on the market close of your choice. About mylan Inc. [MYL]: mylan Inc., which provides products to customers in more...

Mylan Announces Enhancements to Executive Management Team

... PITTSBURGH, July 29 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced several key ...he former Merck Generics businesses and in helping mylan to become one of world's largest, quality pharmace.... In addition, Timothy B. Sawyer has joined mylan as senior vice president of Strategic Corporate De...

Mylan Reports That the FDA Determined That All Accusations Were Unfounded

... PITTSBURGH, July 28 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today reported that in addit...ve actions were fully implemented by Mylan. mylan Chairman and CEO Robert J. Coury said: "I want to ...et and our stakeholders take note of this." mylan Inc., which provides products to customers in more...

Mylan Reiterates and Stands Behind Its 48-Year Commitment and Track Record of Quality

... PITTSBURGH, July 26 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) released the following response to a news article pub...ectively. This issue had no impact on the quality of our product." mylan Inc., which provides products to customers in more than 140 countries and t...

Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol

... PITTSBURGH, July 20 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary mylan Pharmaceuticals Inc. has received approval from th...1 for the same strengths, according to IMS Health. mylan has begun to ship this product. Currently...

Mylan Declares Quarterly Preferred Stock Dividend

... PITTSBURGH, July 20 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that in accordance with its 2.139 mil...009, to holders of preferred stock of record as of August 1, 2009. mylan Inc., which provides products to customers in more than 140 countries and t...

Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R)

... PITTSBURGH, July 16 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary mylan Pharmaceuticals Inc. has received approval from th...1 for the same strengths, according to IMS Health. mylan has begun to ship this product. Currently...
Mylan in Medical Technology

PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies

...EY LP, PARI's LC Plus nebulizer and PRONEB compressors (Ultra and Ultra II) were used to show that nebulized formoterol fumarate (Perforomist, DEY LP, mylan Inc.) improves pulmonary function. "We are pleased that researchers chose PARI products as the exclusive nebulizer systems for recent studies co...

Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent

...ed lawsuits against each of Mutual Pharmaceutical Company, Inc. ("Mutual"), mylan Pharmaceuticals Inc. ("Mylan") and Impax Laboratories, Inc. ("Impax") in t...ANDAs") to the U.S. Food and Drug Administration ("FDA") by each of Mutual, mylan and Impax requesting approval to manufacture and sell generic versions of D...

Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI

... Inhalation Solution. Dey, L.P. is a subsidiary of mylan Inc. (NYSE: MYL ). About COPD(1) COPD refers ...ce. About Dey, L.P. Dey, L.P., a subsidiary of mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical ... and http://www.perforomist.com . About Mylan mylan Inc., which provides products to customers in more...

NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium

...ta in January 2007 brought established alliances with a number of additional companies, such as Baxter, GlaxoSmithKline (GSK), Merck Generics (part of mylan Inc), UCB and Otsuka, as well as providing revenue streams, complementary products and critical mass. For further information, please visit Vectura's ...

Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients

...y.(4) COPD patients may consider asking their doctor whether nebulized treatment may be right for them. About Dey, L.P. Dey, L.P., a subsidiary of mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for th...

Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone

...d markets Perforomist(TM) Inhalation Solution. Dey, L.P. is a subsidiary of mylan Inc. (NYSE: MYL ). About Perforomist(TM) Inhalation Solution Indicatio...tment may be right for them. About Dey, L.P. Dey, L.P., a subsidiary of mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical company focused on the de...

Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD

... Inhalation Solution. Dey, L.P. is a subsidiary of mylan Inc. (NYSE: MYL ). About Perforomist(TM) Inhalat...tors. About Dey, L.P. Dey, L.P., a subsidiary of mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical ... . Perforomist is a trademark of Dey, L.P. About mylan ...

Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007

...tors. About Dey, L.P. Dey, L.P., a subsidiary of mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical ... . Perforomist is a trademark of Dey, L.P. About mylan mylan Inc. is one of the world's leading quality generic...
Mylan in Biological News

Scientists Propose Sweeping Changes to Naming of Bird Neurosystems to Acknowledge Their True Brainpower

... The Food and Drug Administration (FDA) has granted approval to mylan Technologies, Inc., for the first generic version of Alza Corporation's Duragesic Patch (Fentanyl Transdermal System) used to treat patients suffering...

FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain

... The Food and Drug Administration (FDA) has granted approval to mylan Technologies, Inc., for the first generic version of Alza Corporation's Duragesic Patch (Fentanyl Transdermal System) used to treat patients suffering...
Mylan in Biological Technology

Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, March 20 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) announces that it has filed a lawsuit in the U.S. District Court of the Southern District of New York against Mylan Inc., Mylan Pharmaceuticals Inc. and Matrix Laboratories...

Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals

FRAZER, Pa. and PHILADELPHIA, Nov. 26 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) and Eurand, Inc. (Nasdaq: EURX ) today announced that they have filed a lawsuit in U.S. District Court in Delaware against Mylan Pharmaceuticals, Inc. and its subsidiary, Mylan, Inc., and Barr Pharma...

Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, February 9 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ), announces that it has received Paragraph IV Notice letters from Barr Laboratories, Inc. ("Barr) and Mylan, Inc. ("Mylan) dated 2 and 4 February 2009 respectively, advisi...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

... PITTSBURGH, July 30 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced its financia... yet another successful quarter on many fronts for mylan as, across the board, we delivered another quarter...lproex Sodium Extended-release (Divalproex), which mylan launched in the first quarter of 2009. ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...edical Enters into Agreement with BrachySciences II-78 Signet Enters into Agreement with AsymmetRx to Distribute 'Prostate-63' Tests II-79 mylan Pharmaceuticals Obtains FDA Approval for Finasteride's ANDA II-79 Aeterna Zentaris Enters into Agreement with Nippon Kayaku II-79 Progenics Ph...

Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)

... PITTSBURGH, July 7 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary mylan Pharmaceuticals Inc. has received approval from th...31 for the same strength, according to IMS Health. mylan has begun to ship this product. Currently,...

Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market

... PITTSBURGH, June 29 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that it has ... the global marketplace. Through this partnership, mylan and Biocon bring together highly complementary cap...harmaceutical industry, and through this alliance, mylan and Biocon have covered all four corners of what a...

Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period

...ing period of exclusivity PITTSBURGH, June 3 /PRNewswire-FirstCall/ -- mylan Inc.'s (Nasdaq: MYL ) Chief Operating Officer Heather Bresch today testif...ittee hearing can be found at www.mylan.com/breschtestimony060309 . mylan Inc., which provides products to customers in more than 140 countries and t...

Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)

... PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that it has ... for asthma and allergy treatment. Currently, mylan has 117 ANDAs pending FDA approval representing $8... annual brand sales, according to IMS Health. mylan Inc., which provides products to customers in more...

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder

...PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of mylan Inc. (Nasdaq: MYL ), today announced that it has...year agreement with Bristol-Myers. Manufactured by mylan subsidiary mylan Technologies Inc. (MTI), EMSAM is a registered tra...
Other Tags
(Date:9/1/2014)... be able to convince your brain that healthy foods taste ... included eight overweight and obese people who were enrolled in ... react to different foods. These participants were compared to a ... in the program. Both groups had MRI brain scans ... later. The scans revealed that the people in the weight-loss ...
(Date:9/1/2014)... 2014 An operating theatre or operating ... performing surgical operations. An operating room comprises a myriad ... operating room lights, imaging displays as well as integration ... Transparency Market Research, a U.S.-based market research firm, the ... 4.5 billion by 2019. , According to this ...
(Date:9/1/2014)... Dennis Thompson HealthDay Reporter ... Ebola drug previously given to two American aid workers successfully ... in laboratory tests, researchers report. The drug, ZMapp, prompted ... they didn,t get the medication until five days after infection. ... who were days or even hours away from death, said ...
(Date:9/1/2014)... The National Association of Hispanic Nurses ... Bazarko, DNP, MPH, RN, and Adriana Perez, PhD, Rn, ... of Nursing. They will be inducted with Immediate Past ... induction we reported last May. , Our three members ... 2014 American Academy of Nursing Policy Conference in Washington, ...
(Date:9/1/2014)... involved in federally-filed Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ) are ... where issues related to claims involving the pain reliever ... Bernstein Liebhard LLP reports. , According to a ... the meeting is scheduled to take place on September ... of several Tylenol conferences that have taken place this ...
Breaking Medicine News(10 mins):Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4
(Date:8/29/2014)... connections in transcription factor networks (TFNs) to evaluate the ... in PLOS Computational Biology in August. ... a network,s resilience against mutations. , "In simulations, ... models has a greater effect on robustness than varying ... Dov A. Pechenick, PhD, lead author and former researcher ...
(Date:8/29/2014)... twist them, fold them: modern materials that are light, ... as artificial skin or electronic paper. , Making such ... but a new way of working with copper nanowires ... , Previous success in the field of ultra-lightweight ... precious gold and silver nanowires. , By turning ...
(Date:8/28/2014)... study reports that an expansion of marine protected areas ... ecological functions. According to investigators from the Wildlife ... fish have focused on saving the largest numbers of ... provide key and difficult-to-replace ecological functions. , ... by fish species that also are food for millions ...
Breaking Biology News(10 mins):Assortativity signatures of transcription factor networks contribute to robustness 2Copper shines as flexible conductor 2Study finds marine protected areas inadequate for protecting fish and ocean ecology 2
Other Contents